Blood volume analysis as a guide for dry weight determination in chronic hemodialysis patients: a crossover study

Abstract

BackgroundVolume overload and depletion both lead to high morbidity and mortality. Achieving euvolemia is a challenge in patients with end stage kidney disease on hemodialysis (HD). Blood volume analysis (BVA) uses radiolabeled albumin to determine intravascular blood volume (BV). The measured BV is compared to an ideal BV (validated in healthy controls). We hypothesized that BVA could be used in HD to evaluate the adequacy of the current clinically prescribed “estimated dry weight” (EDW) and to titrate EDW in order to improve overall volume status. We were also interested in the reproducibility of BVA results in end stage kidney disease.MethodsTwelve adults on chronic HD were recruited; 10 completed the study. BVA (Daxor, New York, NY, USA) was used to measure BV at baseline. EDW was kept the same if the patient was deemed to be euvolemic by BVA otherwise, the prescribed EDW was changed with the aim that measured BV would match ideal BV. A second BVA measurement was done 1–3 months later in order to measure BV again.ResultsBased on BVA, 6/10 patients were euvolemic at baseline and 5/10 were euvolemic at the second measurement. When comparing patients who had their prescribed EDW changed after the initial BVA to those who did not, both groups had similar differences between measured and ideal BV (P = 0.75). BV values were unchanged at the second measurement (P = 0.34) and there was no linear correlation between BV change and weight change (r2 = 0.08).ConclusionsThis pilot study is the first longitudinal measurement of BVA in HD patients. It revealed that changing weight did not proportionally change intravascular BV. BV remained stable for 1–3 months. BVA may not be helpful in clinically stable HD patients but studies on patients with hemodynamic instability and uncertain volume status are needed.Trial registrationClinicalTrials.gov (NCT02717533), first registered February 4, 2015.

Ultrasonographic Assessment of Extravascular Lung Water in Hospitalized Patients Requiring Hemodialysis: A Prospective Observational Study

“…While achieving optimal volume status is crucial for patients undergoing HD, assessing the dry weight remains challenging. There is no consensus regarding the optimal method of extracellular volume assessment in HD patients [2, 3]. Volume assessment is usually based on clinical judgment [4], but dry weight estimation is subjective and can often be inaccurate and differ significantly from the actual dry weight.…”

Incidence of hospital admissions in bioimpedance‐guided fluid management among maintenance hemodialysis patients—Results of a randomized controlled trial

“…(c) Increased ultrafiltration in patients with overhydration not clinically apparent but detected by bioimpedance, may not reduce cardiovascular overload. There is a nonlinear relationship between the change in body weight and blood volume during hemodialysis 24 probably due to the wide variability in the percentage of weight loss from intravascular fluid (54 to 99%) 25 . There are cases described in which blood volume and body weight change even in opposite directions during hemodialysis 25 .…”

Feasibility of Dialysate Bolus-Based Absolute Blood Volume Estimation in Maintenance Hemodialysis Patients

“…ABV can be measured using a variety of invasive, timeconsuming methods, which are of little use in the clinical setting. Common methods range from radioactive tracer injection (26,27) and CO-rebreathing (28,29) to dye approaches [e.g., with indocyanine green (30,31)]. Since 2014, Kron et al published multiple articles on an abridged method to determine the patient's ABV during HD sessions (32)(33)(34)(35)(36)(37).…”